Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRVBiotechnology
Healthcare
$1.40 +3.16%
+$0.05 today
- Market cap
- $60.08M
- Beta
- 1.91
- P/E (TTM)
- -0.8
- EPS (TTM)
- -$2.00
52W Low $1.15High $3.56
Volume 0.37M
Average 0.60M
Price history
Acrivon Therapeutics, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-40.68%
Period high
$3.01
Period low
$1.29
Latest
$1.40
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 6, 2026 | Nov 6, 2026 | |
| 4 | Oct 26, 2026 | Oct 26, 2026 | |
| 4 | Oct 7, 2026 | Oct 7, 2026 | |
| 3 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Sep 2, 2026 | Sep 2, 2026 | |
| 4 | Aug 27, 2026 | Aug 27, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| 4 | Aug 20, 2026 | Aug 20, 2026 | |
| SC 13G/A | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| S-8 | Aug 12, 2026 | Aug 12, 2026 |
Competitors
Who does Acrivon Therapeutics, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about ACRV's filings, answered from its disclosures.
What is the latest ACRV filing?
The latest filing shown is 8-K dated Nov 10, 2026.
How many recent filings does ACRV have?
Intrinsic Alpha currently shows 20 recent filings for ACRV.
Continue the stock analysis
Jump to another research area for this company.